Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approach

被引:0
|
作者
Changpeng Hu
Yue Dai
Huyue Zhou
Jing Zhang
Dandan Xie
Rufu Xu
Mengmeng Yang
Rong Zhang
机构
[1] The Second Affiliated Hospital of Army Medical University,Department of Pharmacy
来源
Hereditas | / 159卷
关键词
COVID-19; Cancer patients; GINS1; Bioinformatics analyses; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Therapeutic approach in acute leukemia patients in the COVID-19 era
    Ramos-Penafiel, Christian
    Zapata-Canto, Nidia
    Demichelis-Gomez, Roberta
    Alvarez-Vera, Jose L.
    Arana-Luna, Luara L.
    De La Pena-Celaya, Jose A.
    Espitia-Rios, Maria E.
    Hernandez-Ruiz, Eleazar
    Perez-Zuniga, Juan M.
    Alvarado-Ibarra, Martha
    GACETA MEDICA DE MEXICO, 2021, 157 : 29 - 34
  • [32] Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients
    Tahamtan, Alireza
    Tavakoli-Yaraki, Masoumeh
    Salimi, Vahid
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (10) : 965 - 967
  • [33] HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
    Street, Maria Elisabeth
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 (02): : 73 - 75
  • [34] Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach
    Shen, Jiemiao
    Gong, Xing
    Ren, Haili
    Tang, Xia
    Yu, Hairong
    Tang, Yilu
    Chen, Shen
    Ji, Minghui
    BMC CANCER, 2025, 25 (01)
  • [35] Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments
    Barlesi, Fabrice
    Foulon, Stephanie
    Bayle, Arnauld
    Gachot, Bertrand
    Pommeret, Fanny
    Willekens, Christophe
    Stoclin, Annabelle
    Merad, Mansouria
    Griscellil, Franck
    Micol, Jean-Baptise
    Sun, Roger
    Nihouarn, Thomas
    Balleygier, Corinne
    Andre, Fabrice
    Scotte, Florian
    Besse, Benjamin
    Soria, Jean-Charles
    Albiges, Laurence
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
    Singh, Rachana
    Singh, Pradhyumna Kumar
    Kumar, Rajnish
    Kabir, Md. Tanvir
    Kamal, Mohammad Amjad
    Rauf, Abdur
    Albadrani, Ghadeer M.
    Sayed, Amany A.
    Mousa, Shaker A.
    Abdel-Daim, Mohamed M.
    Uddin, Md. Sahab
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] Characteristics and Outcomes of 35 Breast Cancer Patients Infected With COVID-19
    Zhang, Bo
    Xie, Rong
    Hubert, Shawna M.
    Yu, Yuanhang
    Zhang, Yue
    Lei, Xiao
    Deng, Wei
    Chen, Jianying
    Li, Yunqiao
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases
    Rahman, Md Habibur
    Rana, Humayan Kabir
    Peng, Silong
    Kibria, Md Golam
    Islam, Md Zahidul
    Mahmud, S. M. Hasan
    Moni, Mohammad Ali
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 138
  • [39] HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
    Chen, Ruochan
    Huang, Yan
    Quan, Jun
    Liu, Jiao
    Wang, Haichao
    Billiar, Timothy R.
    Lotze, Michael T.
    Zeh, Herbert J.
    Kang, Rui
    Tang, Daolin
    HELIYON, 2020, 6 (12)
  • [40] Protease-activated receptor 1 as a potential therapeutic target for COVID-19
    Rovai, Emanuel S.
    Alves, Tomaz
    Holzhausen, Marinella
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (06) : 688 - 694